Please login to the form below

Not currently logged in
Email:
Password:

Therapy Area

This page shows the latest Therapy Area news and features for those working in and with pharma, biotech and healthcare.

Moderna inks R&D agreements with Vertex and Chiesi

Moderna inks R&D agreements with Vertex and Chiesi

As part of that deal, Moderna will receive $25m upfront as well as a potential $400m in milestone payments to conduct research and development activities in this therapy area. ... The condition affects around two to five million adults across the globe,

Latest news

More from news
Approximately 0 fully matching, plus 253 partially matching documents found.

Latest Intelligence

  • Why pharma must trust the science of behaviour Why pharma must trust the science of behaviour

    One area of behavioural science that can be readily transferred into the healthcare arena is nudge theory. ... It’s therefore important to invest time and resource to insight gathering; what are the truths when it comes to a brand, market/therapy area

  • The big issue The big issue

    Again, think of your colleagues: compared to a generation ago, they now specialise not only by discipline but also by sub-discipline, geography and therapy area.

  • War games: why brand teams need a cunning plan that cannot fail War games: why brand teams need a cunning plan that cannot fail

    This typically means defining all your different audience groups, mapping out the various archetypes and personas within them, and understanding current beliefs in your therapy area. ... Pharma’s ability to factor behavioural understanding into

  • China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances

    Government policy amendments have accelerated the regulatory pathway, which is important as cell therapy had been a controversial area,” added Xiaofeng, who was born in China and has a PhD in ... There was no robust, regulatory control but that has

  • Why pharma should invest in the education of doctors Why pharma should invest in the education of doctors

    Given that the patent life of a drug is 10-15 years, and most companies’ pipelines contain multiple drugs in the same therapy area, it makes sense to invest in building

More from intelligence
Approximately 0 fully matching, plus 52 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 80 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics